SRx Health Solutions, Inc. 8-K
Research Summary
AI-generated summary
SRx Health Solutions Redeems Series A Convertible Preferred Stock for $21.77M
What Happened
SRx Health Solutions, Inc. (SRXH) filed a Form 8-K (Regulation FD disclosure) on February 12, 2026 reporting that the company notified holders on February 9, 2026 of its intent to redeem all issued and outstanding Series A Convertible Preferred Stock pursuant to the certificate of designations. On February 11, 2026 the company redeemed all 17,418 issued and outstanding shares of the Preferred Stock for an aggregate redemption price of approximately $21,772,500. A press release announcing the redemption was published on February 11, 2026 and is attached to the filing as an exhibit.
Key Details
- Redeemed shares: 17,418 shares of Series A Convertible Preferred Stock (all issued and outstanding).
- Redemption amount: approximately $21,772,500 aggregate price.
- Notice and timing: notice to holders given Feb 9, 2026; redemption completed Feb 11, 2026.
- Governing document: redemption made pursuant to Section 9 of the Preferred Stock Certificate of Designations filed Oct 27, 2025.
Why It Matters
This action removes the company’s outstanding Series A convertible preferred security from its capital structure and settles the associated claims for the stated cash amount. Because the redeemed shares were convertible, their removal eliminates a potential source of future dilution to common shareholders. Investors should review the company’s press release and future filings for details on the payment source, any effects on cash and liquidity, and any related accounting impacts disclosed by the company.